Summary
Mebendazole-14C was incubated with the 10,000g and 100,000g supernatant fractions and the microsomal fractions of pig, rat and dog liver. The metabolism progressed remarkably slowly. The metabolites were separated by extraction and thin-layer chromatography, and characterized by comparative thin-layer chromatography and mass spectrometry. The major metabolite was methyl[5-(α-hydroxy-α-phenylmethyl)-lH-benzimidazol-2-yl]carbamate, resulting from a reduction of the ketone of mebendazole. After 4 hours, this metabolite accounted for 50, 58 and 93 % of the total radioactivity for the pig, rat and dog 10,000g supernatant fractions respectively. The 100,000g supernatant fractions as well as the microsomal fractions of the three different species contained reductases able to reduce the ketone of mebendazole. A second metabolite (2-amino-lHyl)phenylmethanone, resulting from a carbamate hydrolysis, was only formed with the 10,000 g supernatant and the microsomal fraction of pig liver (about 5 % after 4 hours); this metabolic pathway was shown to be inhibited by SKF-525 A.
Similar content being viewed by others
Reference
Brugmans, J. P., Thienpont, D. C., Van Wijngaarden, I., Vanparijs, O. F., Schuermans, V. L. and Lauwers, H. L., 1971, Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects. J. Am. Med. Assoc.,217, 313–316.
Chavarria, A. P., Swartzwelder, J. C, Villarejos, V. M. and Zeledon, R., 1973, Mebendazole, an effective broad-spectrum anthelmintic. Am. J. Trop. Med. Hyg.,22, 592–595.
Bennett, D. G., 1973, Efficacy of mebendazole as an anthelmintic in horses. Vet. Med. Small Anim. Clin.,68, 604–609.
Nitz, K. J., 1974, Die anthelminthische Wirkung von Mebendazol als Medizinalfutter bei Schweinen. Tieraerztl. Umsch.,29, 495–496.
Vanparijs, O. and Thienpont, D., 1973, Anthelminthische Wirkung des Mebendazols gegen Nematoden und Zestoden bei Hunden. Dtsch. Tieraerztl. Wochenschr.,80, 320–322.
Heykants, J. J. P., unpublished results.
Gillette, J. R., 1971, Fundamentals of Drug Metabolism and Drug Disposition (Ed. La Du, B. N., Man-del, H. G. and Way, E. L.), 400–418, The Williams and Wilkins Co., Baltimore.
Van Gelder, J. L. H., Raeves, L. F. C. and Raeymaekers, A. H. M., 1972, USA Pat. nr. 3,657, 267.
Meuldermans, W. E. G., Lauwers, W. F. J. and Heykants, J. J. P., 1976,In vitro metabolism of etomidate by rat liver fractions. Arch. Int. Pharmacodyn. Ther., in press.
Lowry, O. M., Rosebrough, N. J., Farr, A. L. and Randall, R. J., 1951, Protein measurement with the folin phenol reagent. J. Biol. Chem.,193, 265–275.
Peeters, J., unpublished results.
Meuldermans, W. E. G., Lauwers, W. F. J., Knaeps, A. G., Michiels, L.J. M. and Heykants, J.J. P.,In vitro metabolism of azaperone by rat and pig liver fractions, in preparation.
Robertson, J. S. and Hussain, M., 1972, The metabolism of oxoquinozilidines in rabbits. Xenobiotica,2, 539–549.
Leinweber, F.-J., Greenough, R. C, Schwender, C. F., Kaplan, H. R. and Di Carlo, F. J., 1972, Bunolol metabolism by cell-free preparations of human liver: biosynthesis of dihydrobunolol. Xenobiotica,2, 191–202.
Kahl, G. F., 1970, Experiments on the metyrapone reducing microsomal enzyme system. Naunyn-Schmiedebergs Arch. Pharmakol.,266, 61–74.
Lan, S. J., El-Hawey, A. M., Dean, A. V. and Schreiber, E. C., 1975, Metabolism ofp-(cyclopropylcarbonyl) phenylacetic acid (SQ 20, 650). Species differences. Drug Metabolism and Disposition,3, 171–179.
Douch, P. G. C., Smith, J. N. and Turner, J. C., 1971, NADPH-dependent cleavage of carbamates. Life Sci.,10, Pt II, 1327–1333.
Douch, P. G. C., 1973, The metabolism of benomyl fungicide in mammals. Xenobiotica,3, 367–380.
Ryrfeldt, A., 1970, The distribution, elimination and biotransformation of14C-cloforex in the mouse and rat. Acta Pharmacol. Toxicol.,28, 391–405.
Thienpont, D., unpublished results.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meuldermans, W.E.G., Hurkmans, R.M.A., Lauwers, W.F.J. et al. Thein vitro metabolism of mebendazole by pig, rat and dog liver fractions. European Journal of Drug Metabolism and Pharmacokinetics 1, 35–40 (1976). https://doi.org/10.1007/BF03192277
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03192277